IL158172A0 - Pharmaceutical compositions containing (-)-hydroxycitric acid - Google Patents
Pharmaceutical compositions containing (-)-hydroxycitric acidInfo
- Publication number
- IL158172A0 IL158172A0 IL15817202A IL15817202A IL158172A0 IL 158172 A0 IL158172 A0 IL 158172A0 IL 15817202 A IL15817202 A IL 15817202A IL 15817202 A IL15817202 A IL 15817202A IL 158172 A0 IL158172 A0 IL 158172A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- hydroxycitric acid
- hydroxycitric
- acid
- Prior art date
Links
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N (+)-Erythro-hydroxycitric acid Natural products OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 title 1
- ZMJBYMUCKBYSCP-AWFVSMACSA-N (1s,2r)-1,2-dihydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)[C@@H](O)[C@@](O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-AWFVSMACSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28059301P | 2001-03-30 | 2001-03-30 | |
US34347301P | 2001-12-20 | 2001-12-20 | |
PCT/US2002/010368 WO2002078616A2 (en) | 2001-03-30 | 2002-04-01 | Methods for increasing serotonin levels by administering (-)-hydroxycitric acid |
Publications (1)
Publication Number | Publication Date |
---|---|
IL158172A0 true IL158172A0 (en) | 2004-03-28 |
Family
ID=26960381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15817202A IL158172A0 (en) | 2001-03-30 | 2002-04-01 | Pharmaceutical compositions containing (-)-hydroxycitric acid |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1379261A4 (en) |
JP (1) | JP2004526738A (en) |
AU (1) | AU2002305132B2 (en) |
CA (1) | CA2442370A1 (en) |
IL (1) | IL158172A0 (en) |
MX (1) | MXPA03008939A (en) |
NZ (1) | NZ528681A (en) |
WO (1) | WO2002078616A2 (en) |
ZA (1) | ZA200307594B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001527022A (en) | 1997-07-14 | 2001-12-25 | ラジュ、ジー・ガンガ | Hydroxycitric acid compositions, supplements and supplements and foods made therefrom and methods of using them in reducing body weight |
US7119110B2 (en) | 2001-10-05 | 2006-10-10 | Interhealth Nutraceuticals Incorporated | Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
US20030119913A1 (en) | 2001-12-20 | 2003-06-26 | Ohia Sunny E. | Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof |
US8394856B2 (en) | 2002-07-02 | 2013-03-12 | Glykon Technologies Group, Llc | (-)-Hydroxycitric acid for controlling inflammation |
TW200427447A (en) * | 2003-03-21 | 2004-12-16 | Interhealth Nutraceuticals Inc | Method and composition for decreasing ghrelin levels |
US20050215644A1 (en) * | 2004-03-19 | 2005-09-29 | Interhealth Nutraceuticals, Inc. | Methods for increasing neurotransmitter levels using hydroxycitric acid |
EP4157254A1 (en) * | 2020-06-02 | 2023-04-05 | Glykon Technologies Group, LLC. | Methods and pharmaceutical preparations for elevating ketone utilization |
WO2021247291A1 (en) * | 2020-06-02 | 2021-12-09 | Glykon Technologies Group, Llc | Methods and pharmaceutical preparations for elevating blood hemoglobin and oxygen saturation levels with hydroxycitric acid |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5612039A (en) * | 1994-03-14 | 1997-03-18 | Nini E. Policappelli | Dietary supplement |
US5626849A (en) * | 1995-06-07 | 1997-05-06 | Reliv International, Inc. | Weight loss composition for burning and reducing synthesis of fats |
IT1276253B1 (en) * | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR ALCANOIL L-CARNITINE FOR THE PREVENTION AND TREATMENT OF SOFT STATES |
WO2000012080A1 (en) * | 1998-09-01 | 2000-03-09 | Amway Corporation | Diet composition and method of weight management |
US6207714B1 (en) * | 1999-09-14 | 2001-03-27 | Dallas L. Clouatre | Methods and pharmaceutical preparations for improving glucose metabolism with (−)-hydroxycitric acid |
-
2002
- 2002-04-01 IL IL15817202A patent/IL158172A0/en unknown
- 2002-04-01 WO PCT/US2002/010368 patent/WO2002078616A2/en active IP Right Grant
- 2002-04-01 CA CA002442370A patent/CA2442370A1/en not_active Abandoned
- 2002-04-01 JP JP2002576884A patent/JP2004526738A/en active Pending
- 2002-04-01 EP EP02733934A patent/EP1379261A4/en not_active Withdrawn
- 2002-04-01 AU AU2002305132A patent/AU2002305132B2/en not_active Expired
- 2002-04-01 NZ NZ528681A patent/NZ528681A/en not_active IP Right Cessation
- 2002-04-01 MX MXPA03008939A patent/MXPA03008939A/en not_active Application Discontinuation
-
2003
- 2003-09-30 ZA ZA2003/07594A patent/ZA200307594B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2442370A1 (en) | 2002-10-10 |
AU2002305132B2 (en) | 2007-05-31 |
ZA200307594B (en) | 2005-05-25 |
EP1379261A4 (en) | 2004-09-08 |
JP2004526738A (en) | 2004-09-02 |
MXPA03008939A (en) | 2005-03-07 |
EP1379261A2 (en) | 2004-01-14 |
WO2002078616A3 (en) | 2002-11-28 |
WO2002078616A2 (en) | 2002-10-10 |
NZ528681A (en) | 2005-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1072200A1 (en) | Pro-micelle pharmaceutical compositions | |
IL162581A0 (en) | Pharmaceutical compositions containing corticosteroids | |
SI1381346T1 (en) | Pharmaceutical compositions containing formoterol | |
EP1450824A4 (en) | Pharmaceutical composition | |
GB0111597D0 (en) | Pharmaceutical compositions | |
IL162213A0 (en) | Pharmaceutical compositions containing active vitamin d compounds | |
EP1407785A4 (en) | Medicinal compositions | |
HK1065944A1 (en) | Medicinal compositions | |
HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
HUP0302847A3 (en) | Pharmaceutical formulation comprising bicalutamide | |
IL159722A0 (en) | Pharmaceutical compositions containing oligonucleotides | |
HUP0303163A3 (en) | Tramadol-based pharmaceutical composition | |
GB0117057D0 (en) | Pharmaceutical composition | |
HUP0400850A3 (en) | Oral pharmaceutical compositions | |
EP1408896A4 (en) | Pharmaceutical composition | |
GB0129117D0 (en) | Pharmaceutical composition | |
GB0116107D0 (en) | Pharmaceutical composition | |
IL158172A0 (en) | Pharmaceutical compositions containing (-)-hydroxycitric acid | |
EP1404303A4 (en) | Stable pharmaceutical compositions containing pravastatin | |
GB0127805D0 (en) | Pharmaceutical composition | |
GB0104752D0 (en) | Pharmaceutical compositions | |
PL370037A1 (en) | Pharmaceutical composition | |
HUP0302531A3 (en) | Pharmaceutical compositions containing citalopram | |
GB2382302B (en) | Pharmaceutical compositions | |
IL160973A0 (en) | Macrolides containing pharmaceutical compositions |